Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1987-01-09
1989-07-04
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514183, 5142248, 5142252, 5142255, 5142258, 5142262, 5142298, A61K 31395, A61K 31535, A61K 3154
Patent
active
048450839
ABSTRACT:
Phenothiazine derivatives and analogs thereof having the Formula I are useful as inhibitors of the biosynthesis of mammalian leukotrienes. As such, these compounds are useful therapeutic agents for treating allergic conditions, asthma, cardiovascular disorders and inflammation, and are useful as cytoprotective agents. ##STR1##
REFERENCES:
patent: 3000885 (1961-09-01), Cusic
patent: 3450698 (1969-06-01), Farge et al.
patent: 3471482 (1969-10-01), Sutton
patent: 3591692 (1971-07-01), Sutton
patent: 3961055 (1976-06-01), Baget
patent: 4148885 (1979-04-01), Renoux et al.
patent: 4667032 (1987-05-01), Lau et al.
patent: 4707473 (1987-11-01), Muchowski et al.
Tambi et al., J. Heterocyclic Chem., vol. 20 (1983), pp. 803-805.
Nodiff et al., J. Heterocyclic Chem., vol. 5 (1968), pp. 165-177.
Chemical Abstracts, 77p (1972), 152198y.
Collier, Can J. Med. Sci, 31 (1953), pp. 195-201.
Collier et al., Can. J. Biochem., vol. 43 (1965), pp. 105-110.
Collier et al., Can. J. Biochem & Physics, vol. 33 (1955), pp. 773-779.
Collier et al., Can. J. Res, vol. 20B (1942), pp. 284-290.
Wightman et al., Biochem. J., vol. 197 (1981), pp. 523-526.
Singh et al., Asian Med. J., vol. 19 (1976), pp. 60-66.
Fishman et al., J. Pharm. Exp. Ther., vol. 150 (1965), pp. 122-128.
Bailey et al., Ann. Rpts. Med. Chem., vol 17 (1982), pp. 203-217.
Bailey et al., Ann. Rpts. Med. Chem., vol. 16 (1981), pp. 213-227.
Baumann et al., Prostaglandins, vol. 20 (1980), pp. 627-639.
Sandler, "Inhibitors of Aarchidonic Acid Metabolism" from Enzyme Inhibitors as Drugs, Univ. Park Press, Baltimore, pp. 249-262.
Mitchell, Drug Met. Rev., vol. 13 (1982), pp. 319-343.
Ellison et al., Am. J. Vet. Res, No. 7 (1957), pp. 519-522.
Rigas et al., Prostaglandins Med. (1981), pp. 183-193.
Perel et al., Neurotoxicology (1977) Raven Press, N.Y., pp. 9-13.
Halpern, Arch. Int'l Pharm. Ther., vol. 74 (1947), pp. 314-333.
Bhargava et al., Gazz. Chem. Ital., vol. 109 (1979), pp. 201-203.
Garry et al., Biochem. Pharm., vol. 21 (1972), pp. 2801-2804.
Mitchell et al., Drug. Metab. Disp., vol. 7 (1979), pp. 399-403.
Akera et al., Biochem. Pharm., vol. 27 (1978), pp. 995-998.
Creese et al., Eur. J. Pharm., vol. 47 (1978), pp. 291-296.
Schenker et al., Progress in Drug Res., vol. 5, E. Tucker Ed., Birkhauser Verlag, Basel, Switzerland (1963), pp. 269-627.
Fortin Rejean
Guindon Yvan
Lau Cheuk K.
Rokach Joshua
Yoakim Christiane
Lopez Gabriel
Merck Frosst Canada Inc.
Pfeiffer Hesna J.
Raymond Richard L.
LandOfFree
Method of inhibiting mammalian leukotriene biosynthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting mammalian leukotriene biosynthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting mammalian leukotriene biosynthesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-852520